Eris Lifesciences Ltd.

BSE: 540596 | NSE: ERIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE406M01024 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Eris Lifescien Eris Lifesciences Ltd. | BSE 1626.00 -5.70 (-0.35%) | NSE 1628.40 0.60 (0.04%) | Trade | Add

BSE Live

Oct 28, 16:01

1626.00 -5.70 (-0.35%)

Volume

AVERAGE VOLUME

5-Day

14,297

10-Day

12,305

30-Day

34,495

5,363

Prev. Close

1631.70
Open Price

1621.35

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Oct 28, 15:59

1628.40 0.60 (0.04%)

Volume

AVERAGE VOLUME

5-Day

249,268

10-Day

212,591

30-Day

244,631

201,102

Prev. Close

1627.80
Open Price

1627.80

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
1628.40 (135)

Financials

Print/Copy to Excel : Go

Profit & Loss account of Eris Lifesciences (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
INCOME
Revenue From Operations [Gross]	2,879.26	1,991.30	1,661.82	1,326.17	1,192.64
Less: Excise/Sevice Tax/Other Levies	0.00	0.00	0.00	0.00	0.00
Revenue From Operations [Net]	2,879.26	1,991.30	1,661.82	1,326.17	1,192.64
Total Operating Revenues	2,893.64	2,009.14	1,685.15	1,347.04	1,211.86
Other Income	18.36	23.82	11.15	26.09	8.71
Total Revenue	2,912.00	2,032.96	1,696.30	1,373.14	1,220.57
EXPENSES
Cost Of Materials Consumed	276.34	177.81	142.20	117.57	99.43
Purchase Of Stock-In Trade	473.12	201.52	206.33	141.72	177.01
Operating And Direct Expenses	0.00	0.00	0.00	0.00	0.00
Changes In Inventories Of FGWIP And Stock In Trade	-35.47	0.72	3.82	-0.78	-38.17
Employee Benefit Expenses	505.09	403.82	346.16	252.25	229.30
Finance Costs	231.29	84.80	26.17	4.15	1.80
Depreciation And Amortisation Expenses	315.46	182.61	117.09	64.71	42.99
Other Expenses	657.36	550.45	449.90	351.32	313.72
Total Expenses	2,423.19	1,601.72	1,291.66	930.94	826.07
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	488.81	431.24	404.64	442.20	394.50
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Profit/Loss Before Tax	488.81	431.24	404.64	442.20	394.50
Tax Expenses-Continued Operations
Current Tax	111.84	82.22	74.66	81.82	69.40
Less: MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	2.36	-48.03	-44.18	-45.42	-30.04
Other Direct Taxes	0.00	0.00	0.00	0.00	0.00
Total Tax Expenses	114.20	34.19	30.48	36.41	39.36
Profit/Loss After Tax And Before ExtraOrdinary Items	374.61	397.05	374.16	405.79	355.14
Profit/Loss From Continuing Operations	374.61	397.05	374.16	405.79	355.14
Profit/Loss For The Period	374.61	397.05	374.16	405.79	355.14
Minority Interest	-22.83	-5.07	8.00	0.32	0.00
Consolidated Profit/Loss After MI And Associates	351.84	391.98	382.16	406.11	355.14
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	26.00	29.00	28.00	30.00	26.00
Diluted EPS (Rs.)	26.00	29.00	28.00	30.00	26.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	100.06	0.00	99.94	81.65	74.68
Tax On Dividend	0.00	0.00	0.00	0.00	0.00